Literature DB >> 15735977

Hypermethylation of Chfr and hMLH1 in gastric noninvasive and early invasive neoplasias.

Naoyuki Homma1, Gen Tamura, Teiichiro Honda, Zhe Jin, Kiyonari Ohmura, Sumio Kawata, Teiichi Motoyama.   

Abstract

Human tumors are genetically unstable, and the instability exists at two distinct levels-the chromosomal level and the nucleotide level. Chfr and hMLH1 hypermethylation, which may lead to chromosomal instability (CIN) and microsatellite instability (MSI), respectively, was analyzed in gastric noninvasive neoplasias (NIN, Padova international classification) and submucosal invasive adenocarcinomas and in their corresponding non-neoplastic gastric epithelia. Results were compared with microsatellite status, p53 immunoreactivity, and cellular phenotype. Hypermethylation of Chfr and hMLH1 was observed in: 10% (1/10) and 0% (0/10) of low-grade NIN (L-NIN); 63% (5/8) and 63% (5/8) of high-grade NIN, including suspicion for carcinoma without invasion (H-NIN); 36% (5/14) and 57% (8/14) of high-grade NIN, including carcinoma without invasion; and 35% (7/20) and 25% (5/20) of submucosal invasive adenocarcinomas, respectively. Hypermethylation was less frequent in L-NIN than H-NIN (P<0.05) for Chfr and was also less frequent in L-NIN than the others (P<0.05) for hMLH1. We failed to find a significant correlation between Chfr hypermethylation and chromosomal loss of heterozygosity, although hypermethylation of hMLH1 was significantly associated with high-frequency MSI (P<0.01). Expression of p53 was not associated with Chfr or hMLH1 methylation. As for cellular phenotype, hypermethylation of Chfr and hMLH1 was frequent in tumors exhibiting the foveolar epithelial phenotype (50%, 2/4 and 75%, 3/4, respectively) and the ordinary phenotype (40%, 16/40 and 38%, 15/40, respectively), but never in those with the complete-type intestinal metaplastic phenotype (0%, 0/8 for both). In addition, hypermethylation of Chfr and hMLH1 occurred concurrently (P<0.01); methylation was more frequent in patients over 70 years of age (P<0.01), and it was also present in some samples of non-neoplastic gastric epithelia from elderly patients. Thus, some gastric tumors with the foveolar or ordinary phenotype may develop as a result of age-related methylation of Chfr and hMLH1, although Chfr methylation was not associated with CIN.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15735977     DOI: 10.1007/s00428-004-1146-6

Source DB:  PubMed          Journal:  Virchows Arch        ISSN: 0945-6317            Impact factor:   4.064


  42 in total

1.  Oncofetal mucin M1 epitope family: characterization and expression during colonic carcinogenesis.

Authors:  J Bara; R Gautier; P Mouradian; C Decaens; N Daher
Journal:  Int J Cancer       Date:  1991-01-21       Impact factor: 7.396

Review 2.  Gastric dysplasia: the Padova international classification.

Authors:  M Rugge; P Correa; M F Dixon; T Hattori; G Leandro; K Lewin; R H Riddell; P Sipponen; H Watanabe
Journal:  Am J Surg Pathol       Date:  2000-02       Impact factor: 6.394

3.  Characterization of MAD2B and other mitotic spindle checkpoint genes.

Authors:  D P Cahill; L T da Costa; E B Carson-Walter; K W Kinzler; B Vogelstein; C Lengauer
Journal:  Genomics       Date:  1999-06-01       Impact factor: 5.736

Review 4.  A National Cancer Institute Workshop on Microsatellite Instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer.

Authors:  C R Boland; S N Thibodeau; S R Hamilton; D Sidransky; J R Eshleman; R W Burt; S J Meltzer; M A Rodriguez-Bigas; R Fodde; G N Ranzani; S Srivastava
Journal:  Cancer Res       Date:  1998-11-15       Impact factor: 12.701

5.  Methylation-induced G(2)/M arrest requires a full complement of the mismatch repair protein hMLH1.

Authors:  Petr Cejka; Lovorka Stojic; Nina Mojas; Anna Marie Russell; Karl Heinimann; Elda Cannavó; Massimiliano di Pietro; Giancarlo Marra; Josef Jiricny
Journal:  EMBO J       Date:  2003-05-01       Impact factor: 11.598

6.  Concerted promoter hypermethylation of hMLH1, p16INK4A, and E-cadherin in gastric carcinomas with microsatellite instability.

Authors:  Hyunki Kim; Yun Hee Kim; Sung Eun Kim; Nam-Gyun Kim; Sung Hoon Noh; Hoguen Kim
Journal:  J Pathol       Date:  2003-05       Impact factor: 7.996

7.  Epigenetic inactivation of CHFR in human tumors.

Authors:  Minoru Toyota; Yasushi Sasaki; Ayumi Satoh; Kazuhiro Ogi; Takefumi Kikuchi; Hiromu Suzuki; Hiroaki Mita; Nobuyuki Tanaka; Fumio Itoh; Jean-Pierre J Issa; Kam-Wing Jair; Kornel E Schuebel; Kohzoh Imai; Takashi Tokino
Journal:  Proc Natl Acad Sci U S A       Date:  2003-06-16       Impact factor: 11.205

8.  The checkpoint protein Chfr is a ligase that ubiquitinates Plk1 and inhibits Cdc2 at the G2 to M transition.

Authors:  Dongmin Kang; James Chen; Jim Wong; Guowei Fang
Journal:  J Cell Biol       Date:  2002-01-21       Impact factor: 10.539

9.  Hypermethylation of the hMLH1 gene promoter in solitary and multiple gastric cancers with microsatellite instability.

Authors:  K Sakata; G Tamura; Y Endoh; K Ohmura; S Ogata; T Motoyama
Journal:  Br J Cancer       Date:  2002-02-12       Impact factor: 7.640

10.  Mutational inactivation of mitotic checkpoint genes, hsMAD2 and hBUB1, is rare in sporadic digestive tract cancers.

Authors:  Y Imai; Y Shiratori; N Kato; T Inoue; M Omata
Journal:  Jpn J Cancer Res       Date:  1999-08
View more
  11 in total

Review 1.  Safeguarding entry into mitosis: the antephase checkpoint.

Authors:  Cheen Fei Chin; Foong May Yeong
Journal:  Mol Cell Biol       Date:  2010-01       Impact factor: 4.272

Review 2.  The multifunctional SNM1 gene family: not just nucleases.

Authors:  Yiyi Yan; Shamima Akhter; Xiaoshan Zhang; Randy Legerski
Journal:  Future Oncol       Date:  2010-06       Impact factor: 3.404

Review 3.  CHFR: a key checkpoint component implicated in a wide range of cancers.

Authors:  Sheru Sanbhnani; Foong May Yeong
Journal:  Cell Mol Life Sci       Date:  2011-12-13       Impact factor: 9.261

Review 4.  Alterations of tumor suppressor and tumor-related genes in the development and progression of gastric cancer.

Authors:  Gen Tamura
Journal:  World J Gastroenterol       Date:  2006-01-14       Impact factor: 5.742

5.  CHFR: A Novel Mitotic Checkpoint Protein and Regulator of Tumorigenesis.

Authors:  Lisa M Privette; Elizabeth M Petty
Journal:  Transl Oncol       Date:  2008-07       Impact factor: 4.243

6.  Checkpoint with forkhead-associated and ring finger promoter hypermethylation correlates with microsatellite instability in gastric cancer.

Authors:  Eiji Oki; Yan Zhao; Rintaro Yoshida; Takanobu Masuda; Koji Ando; Masahiiko Sugiyama; Eriko Tokunaga; Masaru Morita; Yoshihiro Kakeji; Yoshihiko Maehara
Journal:  World J Gastroenterol       Date:  2009-05-28       Impact factor: 5.742

7.  The anti-proliferative effects of the CHFR depend on the forkhead associated domain, but not E3 ligase activity mediated by ring finger domain.

Authors:  Tomokazu Fukuda; Yasuyuki Kondo; Hitoshi Nakagama
Journal:  PLoS One       Date:  2008-03-12       Impact factor: 3.240

8.  RASSF2, a potential tumour suppressor, is silenced by CpG island hypermethylation in gastric cancer.

Authors:  M Endoh; G Tamura; T Honda; N Homma; M Terashima; S Nishizuka; T Motoyama
Journal:  Br J Cancer       Date:  2005-12-12       Impact factor: 7.640

9.  Association between CHFR gene hypermethylation and gastric cancer risk: a meta-analysis.

Authors:  Hua Shi; Xiaojing Wang; Jianbo Wang; Jundi Pan; Junwei Liu; Bin Ye
Journal:  Onco Targets Ther       Date:  2016-12-08       Impact factor: 4.147

10.  Clinicopathological significance of CHFR promoter methylation in gastric cancer: a meta-analysis.

Authors:  Yong Ding; Hai-Feng Lian; Yaowu Du
Journal:  Oncotarget       Date:  2017-12-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.